Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-26-274137
Filing Date
2026-06-17
Accepted
2026-06-17 16:05:13
Documents
11
Period of Report
2026-06-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d14560d8ka.htm   iXBRL 8-K/A 27953
  Complete submission text file 0001193125-26-274137.txt   147846

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA btmd-20260612.xsd EX-101.SCH 2490
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20260612_lab.xml EX-101.LAB 18653
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20260612_pre.xml EX-101.PRE 11655
14 EXTRACTED XBRL INSTANCE DOCUMENT d14560d8ka_htm.xml XML 4789
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40128 | Film No.: 261098304
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)